Minna Turkkila
University of Gothenburg(SE)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Systemic Lupus Erythematosus Research, Cystic Fibrosis Research Advances
Most-Cited Works
- → Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial(2015)420 cited
- → Survivin in autoimmune diseases(2017)79 cited
- → IGF-1R signalling contributes to IL-6 production and T cell dependent inflammation in rheumatoid arthritis(2017)53 cited
- → A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis(2016)45 cited
- → Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis(2017)44 cited
- → Survivin controls biogenesis of microRNA in smokers: A link to pathogenesis of rheumatoid arthritis(2016)25 cited
- → Suppressed diversity of survivin splicing in active rheumatoid arthritis(2015)20 cited
- → Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden(2017)19 cited
- → Survivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA—Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA(2018)10 cited
- → FRI0025 Predicting Rheumatoid Arthritis by Measuring Survivin in Unselected Samples – Epidemiological Study Within Two University Cities of Sweden(2015)2 cited